Page 43 - Sohini Das

Better chip supply fuels passenger vehicle production by 16%: Siam

India's two-wheeler exports down 21% in the month

A strong dose of reality: Households waste 70% medicines, shows survey

1.5% of drugs wasted in domestic market, say pharmacists; of this, 20% at chemist/wholesaler end, reveals survey

Pharmacists have finger on pulse of small towns as demand increases

The Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) is another major reason for the growth in demand for medicines in smaller towns

No brakes on M&M's open bookings, even as capacity addition in top gear

57,000 bookings a month, against 33,000 billings; firm blames semiconductor shortages

Crackdown on FDCs continues, latest ban to affect Rs 824 cr market: Study

72 pharmaceutical companies have brands that fall under banned FDCs, says one expert

Tata Motors looking to increase localisation of electric vehicles to 85%

The group has outlined an investment of Rs 13,000 crore to set up India's first lithium-ion cell manufacturing giga-factory in Gujarat last week

4x4 war goes off-road: Maruti's Jimny has foot on lifestyle SUV throttle

MSIL has been exporting the three-door Jimny since 2021, and plans to start exporting the five-door version of the car

Gambia death fallout: Pharma exports to African market slipped 5% in FY23

Medicines put up for retail sales led the decline in exports

Why global funds are lining up to buy fertility clinics chain Indira IVF

1 in 6 Indian couples in metros grapples with infertility. Indira IVF is the largest player in the Rs 6,000-cr market that offers them a solution

Car dealer inventories rise despite retail sales of PVs up 4% in May

FADA initiates talks with OEMs on recalibrating production plans

USFDA inspections of Indian sites still below pre-Covid-19 levels

Indian pharma was exposed to an average of 9 per cent of overall global inspections from calendar year 2009 (CY09) to the first quarter (Q1) of 2022-23 (FY23)

Centre bans 14 more fixed dose combination drugs on expert recommendation

One of the key FDCs banned by the Centre includes a commonly used medication - Nimesulide and paracetamol combination - which is used to relieve pain and fever

Indiana Ophthalmics faces CDSCO probe; Pharmexcil may suspend membership

CDSCO starts probe based in complaint by Sri Lanka that eyedrops made by the firm are linked to eye infections in more than 30 people

Mahindra and Mahindra bets on horticulture to drive tractor growth

M&M currently enjoys a 42.2 per cent share of India's tractor market (as of year till date)

Sun Pharma back in black with Rs 1,984-crore net profit in Q4 FY23

The company reported an Ebitda of Rs 2,802 crore, up 19.7 per cent YoY, with a resulting Ebitda margin of 25.6 per cent for Q4 of FY23

Recruiting nurses remain a major hurdle to hospital bed expansion

India has a shortfall of 1.37 mn nurses if we wish to meet the World Health Organisation (WHO) recommendations; and globally there is a need for 13 mn nursing professionals

Pfizer suspends sale of three antibiotics in India over technical issues

Investigating matter with contract manufacturer Astral Steritech, says pharma firm

Medical tech firm Medtronic to invest Rs 3,000 cr for Hyderabad R&D centre

Facility employs 800 people and will take up more 1,500 in the next five years

Health Ministry to put 75 mn with hypertension on standard care by 2025

Around 40,000 primary he­alt­hcare medical officers will be trained on standard treatment workflow for NCDs thro­ugh the Shashakt portal, MoHFW said

AI cannot replace human knowledge: Metropolis Healthcare Promoter & MD

In 2021-22, Covid19 business was almost 20-22% of the revenue for most diagnostic companies. The non-Covid19 business is not going to grow by 22% to make it equal